CDKN2A and neoplasm: Despite of its well-known role as a tumor suppressor gene, p16 overexpression - but not expression loss - was linked to adverse tumor parameters, including advanced stage, high grade and shorter survival independently from known prognosticators, including pT stage, nodal stage, BRE grade, hormone receptor state, HER2 and cell proliferation.